Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myocardial bridging.

R E Frank1

  • 1Nationwide Insurance Enterprise, Life Insurance Medical Services, Columbus, OH 43215-2220, USA. frankr1@nationwide.com

Journal of Insurance Medicine (New York, N.Y.)
|October 28, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Membranoproliferative glomerulonephritis.

Journal of insurance medicine (New York, N.Y.)·2005
Same author

Prostate cancer.

Journal of insurance medicine (New York, N.Y.)·2001
Same author

Approach scar revisions after self-inflicted wounds with caution.

Plastic and reconstructive surgery·2000
Same author

Psoriatic arthritis.

Journal of insurance medicine (New York, N.Y.)·1999
Same author

Supraventricular tachycardia vs. Marfan's syndrome.

Journal of insurance medicine (New York, N.Y.)·1996
Same author

Membranous nephropathy: case study.

Journal of insurance medicine (New York, N.Y.)·1995
Same journal

Creating Evidence-Based Ratings and Life Expectancies Medical Impairments.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

The Smoking Dilemma: A Technical Deep Dive.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

Biological Clocks: Ready for Prime Time?

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

GLP-1 Therapies and Mortality Risk: Implications for Life Insurers.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

Identifying Benzodiazepine Abuse: A Report of 3 Cases.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

Between Fear and Adoption: The AI Paradox in Medico-Legal Practice Among National Insurance Physicians.

Journal of insurance medicine (New York, N.Y.)·2026
See all related articles

Human myocardial bridging, a coronary artery anomaly, can cause systolic obstruction and lead to serious cardiac events. Surgical intervention can be curative, offering a good prognosis for affected individuals.

Area of Science:

  • Cardiology
  • Human Anatomy
  • Pathophysiology

Background:

  • Myocardial bridging is an anatomical variation where a coronary artery segment is covered by heart muscle.
  • This condition can lead to systolic obstruction of the coronary artery.

Observation:

  • While all patients with myocardial bridges experience systolic compression, ischemia is thought to occur only when diastolic blood flow is also reduced.
  • Most individuals with myocardial bridging remain asymptomatic.

Findings:

  • Myocardial bridging can manifest in various clinical syndromes, including myocardial infarction and sudden cardiac death.
  • Surgical excision of the myocardial bridge has proven curative for some patients.

Implications:

Related Experiment Videos

  • Understanding the pathophysiology of myocardial bridging is crucial for managing patients and preventing adverse cardiac events.
  • Effective treatments exist to alleviate symptoms and improve the long-term outlook for individuals with this condition.